Metagen Therapeutics Inc. (Headquarters: Tsuruoka City, Yamagata Prefecture; Representative Director and CEO: Taku Nakahara)'s "Stool Donation" initiative has been certified as an eligible project for Tsuruoka City's "Tsuruoka Health Points" program for the fiscal year 2026 (Reiwa 8), effective April 1, 2026. This marks the first time a private company's initiative has been certified as an eligible project for this program.
The "Tsuruoka Health Points" is a system implemented by Tsuruoka City starting April 2025, where points are awarded for health-promoting activities such as undergoing health check-ups and participating in exercise events. It targets residents and workers in Tsuruoka City, who can earn points via Tsuruoka City's official LINE account or other means. Upon reaching every 40 points (40, 80, 120 points), participants can enter a lottery to win commemorative gifts.
The "Stool Donation" initiative, newly certified as an eligible project, is a new social contribution effort where individuals with healthy gut environments provide their stool for the development of new pharmaceuticals utilizing gut bacteria contained in stool. Metagen Therapeutics opened Japan's first stool donation facility, "Tsuruoka Stool Donation Room," in Tsuruoka City in April 2025 and is recruiting "gut bacteria donors" residing in the Shonai region.
From April 1, 2026, residents or workers in Tsuruoka City who apply to become gut bacteria donors (by answering a web questionnaire), undergo examinations for donor registration, or make a stool donation will be awarded these health points.
Through its participation in "Tsuruoka Health Points," Metagen Therapeutics aims to further popularize stool donation and contribute to improving citizens' health awareness.
Overview of "Tsuruoka Health Points" Certification (1) The following three steps implemented by Metagen Therapeutics will be eligible, with 2 points added for participation in each: * Web questionnaire within the gut bacteria donor support service "Chomusubi" * Examinations for donor registration/renewal * Stool donation at the Tsuruoka Stool Donation Room
(2) Participants in the eligible project can accumulate points by selecting the activities they have undertaken, using the Tsuruoka City official LINE account or a paper point card obtainable at Tsuruoka City counters.
(3) Metagen Therapeutics will continuously publicize and disseminate information about the health points program at the Tsuruoka Stool Donation Room and other locations.
Regarding this certification, Narumi Ishizawa, Head of Tsuruoka Stool Donation Room at Metagen Therapeutics Inc., stated:
"Since its opening in April 2025, the Tsuruoka Stool Donation Room has received over 1,200 stool donations thanks to the warm cooperation of the people of Tsuruoka and Shonai. We believe that the stool donation initiative not only contributes to patient treatment through gut bacteria but also provides an opportunity for donors to confront their own health status. We are very pleased that stool donation has been certified as an eligible project for 'Tsuruoka Health Points.' Metagen Therapeutics will continue to challenge new drug development while promoting activities to improve the health of Tsuruoka citizens."
Furthermore, a representative from Tsuruoka City's Health and Sports Division commented:
"Tsuruoka Health Points is a new program that officially launched in April 2025. A key feature of this program is the ease of participation and engagement via the Tsuruoka City LINE account, and we have received interest from many people, with approximately 1,000 LINE participants registered. We are very grateful to be able to collaborate with Metagen Therapeutics Inc. as an eligible point project starting in fiscal year Reiwa 8. Moving forward, we will expand the scope of eligible projects to promote activities that allow citizens to enjoy improving their health."
Tsuruoka Health Points Overview (Tsuruoka City Website) https://www.city.tsuruoka.lg.jp/bunka/sports/sports-news/R6_health_point.html
Gut Bacteria Donor Support Service "Chomusubi" https://chomusubi.metagentx.com/
About Metagen Therapeutics Inc. Metagen Therapeutics Inc. (MGTx) is a venture company spun out from Juntendo University, Keio University, and Tokyo Tech, with the purpose of "continuously fulfilling patients' wishes through microbiome science." We create social impact through microbiome research-based medicine and drug discovery. Based on our "gut microbiota bank," we are promoting "medical service business" and "drug discovery business" aimed at the social implementation of Fecal Microbiota Transplantation (FMT). Currently, we are focusing on the development of treatments for immune diseases (inflammatory bowel disease), cancer, and central nervous system diseases.
<Company Profile> Company Name: Metagen Therapeutics Inc. (Abbreviation: MGTx) Headquarters: 246-2 Mizukami, Kakuganji, Tsuruoka City, Yamagata Prefecture Tokyo Office: Otemachi Building 6F Inspired Lab, 1-6-1 Otemachi, Chiyoda-ku, Tokyo Representative: Taku Nakahara, Representative Director and CEO Established: January 17, 2020 Business Activities: Drug discovery and medical business utilizing microbiome science URL: https://www.metagentx.com
FACT BOX
- Source: PR TIMES
- Category: News